n(g)-iminoethylornithine has been researched along with triphenyltetrazolium in 1 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (triphenyltetrazolium) | Trials (triphenyltetrazolium) | Recent Studies (post-2010) (triphenyltetrazolium) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 707 | 1 | 115 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connell, B; Saleh, TM; Wilson, BC | 1 |
1 other study(ies) available for n(g)-iminoethylornithine and triphenyltetrazolium
| Article | Year |
|---|---|
Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms.
Topics: Analysis of Variance; Animals; Brain Infarction; Drug Interactions; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide; Ornithine; Rats; Relaxin; Tetrazolium Salts | 2006 |